| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/15/2009 | US20090017049 BetaGBP, compositions comprising betaGBP, and related methods and uses thereof |
| 01/15/2009 | US20090017033 Inhibiting receptor activated nuclear factor kappa beta ligand (RANKL); immunoregulation |
| 01/15/2009 | US20090017032 Mammalian cx3c chemokine antibodies |
| 01/15/2009 | US20090017028 Antigen binding fragments (fab fragments) binds to a plurality of beta-chemokines; glomerulonephritis, scleroderrna, cirrhosis, multiple sclerosis, lupus nephritis, atherosclerosis, inflammatory bowel disease or rheumatoid arthritis; antiinflammatory agents |
| 01/15/2009 | US20090017018 Uses of mammalian cytokine: related reagents |
| 01/15/2009 | US20090017016 Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090016991 Rxr Antagonist Treatment Against Multiple Sclerosis |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014653A1 Novel dicarboxylic acid derivatives as S1P1 receptor agonists |
| 01/14/2009 | EP2014303A2 APO-2L receptor agonist and CPT-11 synergism |
| 01/14/2009 | EP2014289A1 Pharmaceutical composition for intracellular acidification with cis-urocanid acid |
| 01/14/2009 | EP2013175A1 p38 MAP KINASE INHIBITORS |
| 01/14/2009 | EP2012814A1 Methods of treating autoimmune diseases |
| 01/14/2009 | EP2012791A2 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors |
| 01/14/2009 | EP2012780A2 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 01/14/2009 | EP2012773A2 Drugs and uses |
| 01/14/2009 | EP1844050B1 Pyrrolopyrimidines useful as inhibitors of protein kinase |
| 01/14/2009 | EP1689771B1 Biologically active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt) |
| 01/14/2009 | EP1565179B1 Composition comprising a carbamic acid derivative, its use as cosmetic and medicine |
| 01/14/2009 | EP1549741B1 Novel endothelial cells, antibodies against said cells and use thereof |
| 01/14/2009 | EP1497309B1 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 01/14/2009 | EP1487486B1 Imidazoquinolineamines as adjuvants in hiv dna vaccination |
| 01/14/2009 | EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof |
| 01/14/2009 | EP1463728B1 Fused cyclic modulators of nuclear hormone receptor function |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1317443B1 Chemokine receptor binding heterocyclic compounds |
| 01/14/2009 | EP1297142B1 Dual specificity antibodies and methods of making and using |
| 01/14/2009 | EP1233948B1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 01/14/2009 | EP1223978B1 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 01/14/2009 | EP1115877B1 Polynucleotide constructs and uses thereof |
| 01/14/2009 | EP1107775B2 Composition containing pyrrolizidine-alkaloid-free petasites |
| 01/14/2009 | EP1051189B2 Vaccine formulation containing a polycation as an adjuvant and sugar-alcohols and low concentrations of anorganic ions |
| 01/14/2009 | EP0948614B1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
| 01/14/2009 | CN101346146A Compounds having cytokine modulating properties |
| 01/14/2009 | CN101343640A Common expression CTLA4Ig and CTLA4 recombinant adenovirus carrier, recombinant adenovirus and uses thereof |
| 01/14/2009 | CN101343606A Life prolonging wine and preparation |
| 01/14/2009 | CN101343332A Method for extracting holothurian polyoses with holothurian processing waste liquor |
| 01/14/2009 | CN101343330A Preparation method for panax ginseng polyoses extract |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343251A Thrombopoietin mimetics |
| 01/14/2009 | CN101343250A Thrombopoietin mimetics |
| 01/14/2009 | CN101343225A Preparation method for high-purity di-coffee mesitoyl quinine acid compounds |
| 01/14/2009 | CN101342366A SOD oxidation resistant composition and preparation thereof |
| 01/14/2009 | CN101342319A Host agent prescription with immunoregulation function and preparation method |
| 01/14/2009 | CN101342313A Health care granular formulation, preparation and application thereof |
| 01/14/2009 | CN101342218A Cactus powder processing method |
| 01/14/2009 | CN101342169A Thrombopoietin mimetics |
| 01/14/2009 | CN101341981A Dietary cure beverage |
| 01/14/2009 | CN100450543C Animal medicine capable of increasing immunologic function of livestock and birds |
| 01/14/2009 | CN100450513C Medicine used for traditional Chinese medical moxibustion therapy, and its preparing method |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476509 Compounds and methods for modulating functions of nonclassical cadherins |
| 01/13/2009 | US7476386 Mixed lipopeptide micelles for inducing an immune response |
| 01/13/2009 | US7476385 Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/08/2009 | WO2009005124A1 Double-stranded rna originating in lactic acid bacterium |
| 01/08/2009 | WO2009005123A1 INTERFERON-β PRODUCTION PROMOTER, AND METHOD FOR PRODUCTION THEREOF |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009004873A1 Prostaglandin derivative-containing aqueous liquid agent |
| 01/08/2009 | WO2009004569A1 Use of intranasally administered pidotimod to enhance antigen-specific humoral and cell-mediated immune response |
| 01/08/2009 | WO2009004302A1 Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease |
| 01/08/2009 | WO2009004094A2 Compounds and methods for the treatment of renal disease |
| 01/08/2009 | WO2009003474A1 The use of monomycolyl glycerol (mmg) as an adjuvant |
| 01/08/2009 | WO2009003291A1 Therapeutics and diagnostics for group a streptococci |
| 01/08/2009 | WO2008012338A3 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012102 Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012073 N-aroyl cyclic amines |
| 01/08/2009 | US20090012065 Therapeutic applications of pro-apoptotic benzodiazepines |
| 01/08/2009 | US20090012059 Dipeptidyl peptidase inhibitors |
| 01/08/2009 | US20090012058 Prophylactic or Therapeutic Agents For Allergic Ophthalmic Diseases or Allergic Nasal Diseases, Comprising Tricyclic Triazolobenzazepine Derivative |
| 01/08/2009 | US20090012039 Use of methylcobalamin nasal spray to treat disorders |
| 01/08/2009 | US20090012036 Stable S-adenosyl-L-methionine |
| 01/08/2009 | US20090012004 HLA binding peptides and their uses |
| 01/08/2009 | US20090011993 Novel strategies for delivery of active agents using micelles and particles |
| 01/08/2009 | US20090011986 Thiosuccinic Acid Derivatives and the Use Thereof |
| 01/08/2009 | US20090011985 Gh secretagogues and uses thereof |
| 01/08/2009 | US20090011499 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells |
| 01/08/2009 | US20090011464 Humanized immunoglubulin reactive with alph4beta7 integrin |
| 01/08/2009 | US20090011018 Sustained release formulation for tacrolimus |
| 01/08/2009 | US20090011013 Tacrolimus Combination Products |
| 01/08/2009 | US20090010986 Polymeric gel delivery system for pharmaceuticals |
| 01/08/2009 | US20090010964 Lipid and Nitrous Oxide Combination as Adjuvant for the Enhancement of the Efficacy of Vaccines |
| 01/08/2009 | US20090010961 Avirulent, immunogenic flavivirus chimeras |
| 01/08/2009 | US20090010953 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
| 01/08/2009 | US20090010950 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 01/08/2009 | US20090010948 Anti-tumor vaccines delivered by dendritic cells devoid of interleukin-10 |
| 01/08/2009 | US20090010943 Peptides associated with HLA-DR MHC class II molecule and involved in Rheumatoid arthritis |
| 01/08/2009 | US20090010938 Short immunomodulatory oligonucleotides |